Bristol Myers Squibb (BMS) will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology, ...
Pharmaceutical Technology on MSN
BMS and Anthropic collaborate for Claude implementation
BMS will roll out Claude to over 30,000 employees, targeting three main areas for near-term impact.
Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform ...
Claude will be deployed across BMS to assist with drug discovery, clinical development, regulatory submissions, manufacturing ...
BMS wants AI agents inside drug discovery, clinical trials, manufacturing and corporate work. BMS will deploy Claude across ...
GlobalData on MSN
BMS and Hengrui forge $15.2bn alliance for early-stage drugs
The two companies will trade the greater Chinese and US rights to certain programmes under their jurisdiction, while working in tandem to progress these assets.
New leaders took over the commercial divisions for Gilead and Bristol-Myers Squibb this week. BMS promoted its international markets head Christopher Boerner to EVP and chief commercial officer, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results